Coronado Industries Appoints Gregoire de Rothschild as Financial Consultant to the Company.

FOUNTAIN HILLS, Ariz. -- Coronado Industries Inc. (OTCBB: CNDO) (www.coronadoindustries.com), the manufacturers of unique proprietary pneumatic devices for the non-invasive treatment of glaucoma through its wholly owned subsidiary, Ophthalmic International (www.ophthalmicinternational.com), is pleased to announce the appointment of Gregoire de Rothschild as a financial consultant to the company. He will be advising management on all matters pertaining to the financial markets with special reference to mergers and acquisitions.

In making the announcement today, Richard Smith, CEO of Coronado Industries, said that he and Coronado's board of directors are delighted to be able to call upon the services of de Rothschild, who has considerable experience in several sectors of domestic and international financial markets with particular expertise in mergers and acquisitions. "We shall be seeking Gregoire's advice and support as we continue to progress Coronado's entry into Europe and several other markets throughout the world. His counsel and contacts will be of considerable help to us," Smith said.

Having begun his career in his native France, Gregoire de Rothschild came to the United States in 1980 and since that time, has advised several companies -- especially small-cap and mid-sized firms -- in providing counsel on investor relations. He is the principal of GDR International Inc., with offices in New York.

de Rothschild said that he was especially pleased to be able to consult with Coronado's management at this time of the company's development. "I particularly like the company's PNT treatment for glaucoma. The market is enormous. Glaucoma has, for too long, been a scourge affecting the lives of millions of people. Coronado's non-invasive treatment is both economical and portable and will, hopefully, be made available to patients around the world. I am happy to assist Coronado's management in making this happen just as soon as possible," he said.

Smith said that de Rothschild's appointment will begin immediately.

Coronado Industries, through its wholly owned subsidiary, Ophthalmic International, is focused on the development and commercialization of its patented procedure as a cost-effective alternative for the treatment of the most common types of glaucoma, which are open angle and pigmentary, as well as for the treatment of ocular hypertension.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.